The role of the complement system in traumatic brain injury (Q77208461)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9729408 AND SRC:MED&resulttype=core&format=json

3 December 2019

review article

1 reference

title

The role of the complement system in traumatic brain injury (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9729408 AND SRC:MED&resulttype=core&format=json

Maria Cristina Morganti-Kossmann

3 December 2019

author

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9729408 AND SRC:MED&resulttype=core&format=json

3 December 2019

author name string

P F Stahel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9729408 AND SRC:MED&resulttype=core&format=json

3 December 2019

T Kossmann

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9729408 AND SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9729408 AND SRC:MED&resulttype=core&format=json

3 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9729408 AND SRC:MED&resulttype=core&format=json

3 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9729408 AND SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

243-256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9729408 AND SRC:MED&resulttype=core&format=json

Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Long term follow up of post acute traumatic brain injury rehabilitation: a statistical analysis to test for stability and predictability of outcome

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Complement biosynthesis in the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

The acute phase response

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat.

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Cerebrospinal fluid and plasma nitrite and nitrate concentrations after head injury in humans

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Antibodies against Mac-1 attenuate neutrophil accumulation after traumatic brain injury in rats

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Antibody-independent complement activation by myelin via the classical complement pathway

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Upregulation of nerve growth factor following cortical trauma.

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Clinical considerations in the reduction of secondary brain injury

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Clinical trials in traumatic brain injury. What can we learn from previous studies?

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

The determination of the complement components C1q, C4 and C3 in serum and cerebrospinal fluid by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Inhibiting the formation of classical C3-convertase on the Alzheimer's β-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Pharmacological strategies in CNS trauma

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

C5a-induced expression of P-selectin in endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Purkinje cell vulnerability to mild traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Central autonomic dysorganization in the early stages of experimental meningitis in rabbits induced by complement-C5A-fragment: a pathophysiological validation of the largest lyapunov exponent of heart rate dynamics

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Molecular pathology of head trauma: altered beta APP metabolism and the aetiology of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury.

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

C5A anaphylatoxin and its seven transmembrane-segment receptor

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Brain glia release factors with opposing actions upon neuronal survival.

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Terminal component of complement C9 in CSF and plasma of patients with MS and aseptic meningitis

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Regional heterogeneity in the response of astrocytes following traumatic brain injury in the adult rat.

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Complement-derived polypeptide C3adesArg as a mediator of inflammation at the blood-brain barrier in a new experimental cat model.

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Intracerebral inflammation after human brain contusion

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Delayed phospholipid degradation in rat brain after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Structure and function of the anaphylatoxins

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Up-regulation of intercellular adhesion molecule 1 in cerebral microvessels after cortical contusion trauma in a rat model

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Epidemiology of head injury.

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Effect of Soluble Complement Receptor-1 on Neutrophil Accumulation after Traumatic Brain Injury in Rats

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Inhibition of complement-factor-5a-induced inflammatory reactions by prostaglandin E2 in experimental meningitis

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

The effect of trauma on serum C3 activation and its correlation with injury severity score in man

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Controlling the complement system in inflammation

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Ischemic and traumatic brain injury: pathobiology and cellular mechanisms

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

[Neurochemical changes and current pharmacological approaches in craniocerebral trauma]

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

The control of homologous lysis

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Complement activation in the central nervous system following blood-brain barrier damage in man.

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

The presence of the complement cascade does not lead to neuronal cell death in primary hippocampal cultures

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Treatment of traumatic brain injury with moderate hypothermia.

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

The outcome of severe closed head injury

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

A Mechanistic Analysis of Nondisruptive Axonal Injury: A Review

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Increased numbers of beta APP-immunoreactive neurones in the entorhinal cortex after head injury

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Mechanisms of C5a and C3a complement fragment-induced [Ca2 ]i signaling in mouse microglia

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Clinical complementology: recent progress and future trends

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Expression of complement in the brain: role in health and disease

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Therapeutic uses of recombinant complement receptors

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Enhanced expression of chemotactic receptors in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Complement C1qB and C4 mRNAs responses to lesioning in rat brain

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Cerebrospinal fluid complement proteins in neurological disease

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

βA4 amyloid protein deposition in brain after head trauma

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Cytokines in neurodegeneration and repair

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis.

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

The blood-brain barrier: morphology, molecules, and neurothelin

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

C5a-mediated release of interleukin 6 by human monocytes

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Complement-mediated neurotoxicity is regulated by homologous restriction

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Basic mechanisms of traumatic brain damage

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Tissue culture demyelination by normal human serum

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats.

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Complement C3 and factor B cerebrospinal fluid concentrations in bacterial and aseptic meningitis

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Bacterial meningitis: complement gene expression in the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

GPI-Anchored Cell-Surface Molecules Complexed to Protein Tyrosine Kinases

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Breakdown of the blood-brain barrier after fluid percussive brain injury in the rat. Part 1: Distribution and time course of protein extravasation

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Neurons express proteins of the classical complement pathway in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Mannose-binding lectin: the pluripotent molecule of the innate immune system

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Activation of complement by myelin: identification of C1-binding proteins of human myelin from central nervous tissue

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Complement gene expression in human brain: comparison between normal and Alzheimer disease cases

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Increased phospholipase C activity after experimental brain injury

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Tissue destruction by neutrophils

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Activation of CPP32-Like Caspases Contributes to Neuronal Apoptosis and Neurological Dysfunction after Traumatic Brain Injury

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Chemotaxis by a CNS macrophage, the microglia

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

The acute-phase response of the brain-injured patient

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(98)50015-0

7 January 2021

10.1016/S0165-0173(98)00015-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9729408 AND SRC:MED&resulttype=core&format=json

3 December 2019

1 reference